11ß-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial. (2023)
Attributed to:
Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-36541-w
PubMed Identifier: 36823106
Publication URI: http://europepmc.org/abstract/MED/36823106
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723